An investigation
was designed to evaluate the effects of three different fixation regimes on the retention of seentonin-like immunoreactivity in rat midbrain tissue sections. The effects of pretreatment with pargyline-HCI and /-tryptophan on the volume fraction of serotonin-like immunoreactive processes were also examined. Rat brain tissue was fixed with 4% paraformaldehyde (Pt), 4% paraformaldehyde-0.2% picric acid-0.05% glutaraldehyde (Pf-Pa-G), or 4% paraformaldehyde-0.2% glutaraldehyde (Pf-G).
Tissue was subsequently processed for immunohistochemistry using a modified peroxi- et al., 1981; Steinbusch, 1981 ; Kohier et al., 1982; Steinbusch and Nieuwenhuys, 1983; Cropper et al., 1984) ; 4% paraformaldehyde and 0. 1 to 0.5% glutaraldehyde (Beitz, 1982; Maley and Elde, 1982; Ruda et al., 1982) ; and a paraformaldehyde-glutaraldehyde-picric acid indicate that even low levels of glutaraldehyde in the fixative significantly decrease serotonin immunoreactivity. Pretreatment with pargyline and tryptophan increased the amount of serotonin immunoreactivity in tissue fixed with Pf-G but not in tissue fixed with Pf. Pretreatment with pargyline and tryptophan is thus recommended when using glutaraldehyde in the fixation process to assure adequate serotonin immunoreactivity. Pretreatment in conjunction with glutaraldehyde fixation, however, appears to cause differential increases in serotonin-like immunoreactivity within brain nuclei that may compromise the interpretation of results. that had not been pretreated with pargyline or tryptophan were also divided into groups of three and perfused with the three fixatives as described above.
Following perfusion, each brain was removed and placed in fresh fixative overnight.
The tissue was then rinsed for several hours in 0. 'Pretreated animals were given 25 mg/kg pargyline-HCI and 100 mg/kg /-tryptophan ip 1 hr prior to perfusion. ..
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